Interaction between warfarin and propafenone in healthy volunteer subjects

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Clinical pharmacology and therapy

• Publication date

  1987-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/clpt.1987.152PMID 3621785
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The metabolic fate of2H-labelled propafenone in man

  2010cited by this paper
• Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences.

  1987cited by this paper
• The warfarin‐sulfinpyrazone interaction: stereochemical considerations

  1986cited by this paper
• Binding of antiarrhythmic drugs to purified human α1-acid glycoprotein

  1985cited by this paper
• Metabolite cumulation during chronic propafenone dosing in arrhythmia

  1985cited by this paper
• Binding of antiarrhythmic drugs to purified human alpha 1-acid glycoprotein.

  1985cited by this paper
• Propafenone disposition kinetics in cardiac arrhythmia

  1984cited by this paper
• Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia.

  1983cited by this paper
• Cooperativity of warfarin binding with human serum albumin induced by free fatty acid anion.

  1978cited by this paper
• High-pressure liquid chromatographic analysis of drugs in biological fluids I. Warfarin.

  1977cited by this paper
• Biological effects of drugs in relation to their plasma concentrations : proceedings of a symposium held by the British Pharmacological Society at the Royal Postrgraduate Medical School, London, on January 4, 1972

  1973cited by this paper
• Determinants of the response to oral anticoagulant drugs in man.

  1970cited by this paper
• [Hemorrhagic diseases].

  1958cited by this paper

• PK/PD interactions of antiarrhythmic drugs and oral anticoagulants in atrial fibrillation patients: clinical implications for stroke and dementia prevention

  2025cites this paper
• Drug Interactions Affecting Antiarrhythmic Drug Use

  2022cites this paper
• Cluj-Napoca, Romania

  2015cites this paper
• Proposal for Warfarin Dosage Guideline during Warfarin-Propafenone Combination Therapy

  2013cites this paper
• Analysis of potential interactions between warfarin and prescriptions in Estonian outpatients aged 50 years or more

  2012cites this paper
• ADME of Cardiovascular Drugs

  2012cites this paper
• Drug Interactions Involving Warfarin: Practice Tool and Practical Management Tips

  2011cites this paper
• Adverse drug reactions in patients with cardiovascular disease.

  2008cites this paper
• Successful Treatment of Propafenone, Digoxin and Warfarin Overdosage with Plasma Exchange Therapy and Rifampicin

  2007cites this paper
• A novel sequence variant in exon 7 of CYP2C9 gene (CYP2C9*24) ina patient on warfarin therapy

  2006cites this paper
• The "pill-in-the-pocket" approach to atrial fibrillation.

  2005cites this paper
• Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

  2005cites this paper
• Drug Interactions and Adverse Reactions

  2005cites this paper
• Systematic overview of warfarin and its drug and food interactions.

  2005cites this paper
• The "pill-in-the-pocket" approach to atrial fibrillation.

  2005cites this paper
• Variability in Cytochrome P450-Mediated Metabolism of Cardiovascular Drugs: Clinical Implications and Practical Attempts to Avoid Potential Problems

  2004cites this paper
• Interactions Between Grapefruit Juice and Cardiovascular Drugs

  2004cites this paper
• Metabolism of antiarrhythmics.

  2004cites this paper
• Transient Intraventricular Conduction Delay Associated with Concurrent Intake of Propafenone and Antineoplastic Agents

  2003cites this paper
• Practical tips for warfarin dosing and monitoring.

  2003cites this paper
• Effetto proaritmico del propafenone in donna con epatopatia: è sempre un farmaco di semplice utilizzo nella pratica clinica?

  2002cites this paper
• Interactions of warfarin.

  2001cites this paper
• The Stereoselective Effects of Bucolome on the Pharmacokinetics and Pharmacodynamics of Racemic Warfarin

  2001cites this paper
• Cardiovascular drug-drug interactions.

  2001cites this paper
• Antiarrhythmic Agents

  2000cites this paper
• Pharmacologic Therapy of Arrhythmias

  1999cites this paper
• Consequences of rifampicin treatment on propafenone disposition in extensive and poor metabolizers of CYP2D6.

  1999cites this paper
• Review : Electrophysiologic and Antiarrhythmic Effects of Propafenone: Focus on Atrial Fibrillation

  1999cites this paper
• Wechselwirkungen von Antikoagulantien mit kardiovaskulären Pharmaka

  1998cites this paper
• [Interactions between anticoagulants and cardiovascular drugs].

  1998cites this paper
• Pharmacokinetic Optimisation of the Treatment of Deep Vein Thrombosis

  1997cites this paper
• Human P450 metabolism of warfarin.

  1997cites this paper
• Clinically Important Drug Interactions with Anticoagulants

  1996cites this paper
• Pharmacokinetic drug interactions. Part 3: Drugs P-Z.

  1995cites this paper
• Concomitant etodolac affects neither the unbound clearance nor the pharmacologie effect of warfarin

  1994cites this paper
• K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes.

  1994cites this paper
• New antiarrhythmic drugs in pediatric use: Propafenone

  1994cites this paper
• Interactions of Warfarin with Drugs and Food

  1994cites this paper
• Clinically Significant Drug Interactions with the Oral Anticoagulants

  1994cites this paper
• Steady-state plasma concentrations of propafenone--chirality and metabolism.

  1994cites this paper
• Clinical Pharmacokinetics in Congestive Heart Failure

  1994cites this paper
• Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

  1993cites this paper
• Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics

  1993cites this paper
• Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites.

  1993cites this paper
• Genetically Determined Adverse Drug Reactions Involving Metabolism

  1993cites this paper
• The pharmacokinetic and pharmacodynamic interaction between propafenone and lidocaine

  1993cites this paper
• Propafenone for cardiac arrhythmias.

  1992cites this paper
• Propafenone for cardiac arrhythmias.

  1992cites this paper
• Theophylline toxicity after propafenone treatment: Evidence for drug interaction

  1992cites this paper
• [Potentiation of the anticoagulant effect of fluindione by propafenone].

  1991cites this paper
• Raised serum levels of desipramine with the antiarrhythmic propafenone.

  1991cites this paper
• Propafenone for malignant ventricular arrhythmia: an analysis of the literature.

  1991cites this paper
• Clinical Pharmacokinetics of Propafenone

  1991cites this paper
• Propafenone.

  1990cites this paper
• Propafenone: a promising new antiarrhythmic agent.

  1990cites this paper
• Propafenone: A Promising New Antiarrhythmic Agent

  1990cites this paper
• Propafenone: A Novel Type Ic Antiarrhythmic Agent

  1989cites this paper
• Effects of Coadministration of Propafenone on the Pharmacokinetics of Digoxin in Healthy Volunteer Subjects

  1989cites this paper
• Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia

  1989cites this paper
• Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.

  1987cites this paper